Study of Patients Admitted to a Cardiac Intensive Care Unit With Acute CardioVascular Disease
Launched by UNIVERSITY HOSPITAL, IOANNINA · Oct 6, 2023
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying patients who are admitted to the Cardiac Intensive Care Unit (CICU) due to serious heart conditions, such as heart failure, heart attacks, or blood clots in the lungs. The goal is to understand more about these patients, including their health outcomes during and after their hospital stay. Researchers want to identify factors that may predict whether patients might experience complications while in the hospital and how they fare one year later. They will also look at major heart-related events that can occur after treatment.
Anyone admitted to the CICU from the Emergency Department or transferred from other hospitals with an urgent heart condition may be eligible to participate, as long as they or their family members agree to take part in the study. There are no specific exclusions, meaning almost all patients in this situation could be included. Participants can expect to be part of a registry that collects important health information, which will help improve care for future patients with similar conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients admitted to the Cardiac Intensive Care Unit (CICU) through the Emergency Department of the UHI
- • All patients transferred to the CICU from other hospital departments or other regional secondary hospitals
- • Patients with an acute cardiovascular disease that requires treatment in a CICU
- • Patients who are under scientific supervision of the 2nd Department of Cardiology
- • Patients (or their relative/legal representatives) that have signed the informed consent form
- • Exclusion Criteria: None
About University Hospital, Ioannina
The University Hospital of Ioannina is a leading clinical research institution in Greece, dedicated to advancing medical knowledge and patient care through rigorous scientific inquiry. As a prominent academic medical center, it offers a multidisciplinary approach to clinical trials, fostering collaboration among healthcare professionals, researchers, and patients. The hospital is equipped with state-of-the-art facilities and adheres to the highest ethical standards, ensuring the safety and well-being of participants. With a focus on innovative therapies and treatment modalities, the University Hospital of Ioannina is committed to contributing to the global body of medical research and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ioannina, Epirus, Greece
Patients applied
Trial Officials
Lampros K Michalis, MD, PhD
Study Director
Professor of Cardiology, Director of the 2nd Cardiology Department, University Hospital of Ioannina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported